0000950170-23-070888.txt : 20231215
0000950170-23-070888.hdr.sgml : 20231215
20231215190408
ACCESSION NUMBER: 0000950170-23-070888
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EGLINTON MANNER CARRIE
CENTRAL INDEX KEY: 0001696776
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 231491868
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4/A
1
ownership.xml
4/A
X0508
4/A
2023-05-18
2023-05-22
0000730272
REPLIGEN CORP
RGEN
0001696776
EGLINTON MANNER CARRIE
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
true
false
false
false
false
Common Stock
2792
D
This Form 4/A amends a Form 4 filed on 5/22/2023 to correct an administrative error, which misreported the number of shares beneficially owned by the reporting person. The correction reflects an increase in the number of shares beneficially owned by the reporting person by 625 shares.
/s/ Kimberly Brown (Attorney in Fact)
2023-12-15